Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,471 | 325 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $883.59 | 44 | $0 (2024) |
| Lilly USA, LLC | $632.60 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $596.94 | 33 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $481.49 | 19 | $0 (2024) |
| PFIZER INC. | $461.02 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $449.58 | 23 | $0 (2024) |
| ABBVIE INC. | $410.92 | 19 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $361.43 | 18 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $324.09 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $201.19 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,920 | 94 | AstraZeneca Pharmaceuticals LP ($291.13) |
| 2023 | $1,759 | 86 | Lilly USA, LLC ($341.68) |
| 2022 | $1,670 | 82 | Novo Nordisk Inc ($282.27) |
| 2021 | $1,122 | 63 | Novo Nordisk Inc ($200.12) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: GI | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: VACCINES | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $14.90 | General |
| 11/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Obesity | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: GI | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: VACCINE | ||||||
| 10/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Diabetes | ||||||
| 09/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 213 | 266 | $68,592 | $21,100 |
| 2022 | 6 | 141 | 189 | $46,988 | $14,495 |
| 2021 | 2 | 87 | 138 | $21,250 | $10,432 |
| 2020 | 6 | 240 | 485 | $58,215 | $21,597 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 113 | $32,996 | $8,760 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $18,178 | $6,807 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 43 | $8,858 | $2,429 | 27.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,888 | $1,853 | 37.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 19 | 24 | $3,072 | $874.79 | 28.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $600.00 | $376.44 | 62.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 87 | $25,404 | $6,875 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 23 | 23 | $6,854 | $2,647 | 38.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $4,136 | $1,610 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 28 | $5,768 | $1,599 | 27.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 18 | $3,726 | $1,087 | 29.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 22 | $1,100 | $676.52 | 61.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 67 | $12,730 | $6,051 | 47.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 71 | $8,520 | $4,381 | 51.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 96 | 251 | $27,359 | $9,589 | 35.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 136 | $21,787 | $8,631 | 39.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 25 | $5,400 | $1,937 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $1,859 | $1,130 | 60.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 27 | 28 | $1,400 | $243.44 | 17.4% |
| 94760 | Measurement of oxygen saturation in blood using ear or finger device | Office | 2020 | 25 | 34 | $410.00 | $67.08 | 16.4% |
About Keith Shields, PA-C
Keith Shields, PA-C is a Physician Assistant healthcare provider based in Cumberland, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2017. The National Provider Identifier (NPI) number assigned to this provider is 1265972350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Keith Shields, PA-C has received a total of $6,471 in payments from pharmaceutical and medical device companies, with $1,920 received in 2024. These payments were reported across 325 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,471).
As a Medicare-enrolled provider, Shields has provided services to 681 Medicare beneficiaries, totaling 1,078 services with total Medicare billing of $67,624. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Cumberland, RI
- Active Since 03/08/2017
- Last Updated 07/28/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265972350
Products in Payments
- FARXIGA (Drug) $441.10
- Ozempic (Drug) $440.28
- HETLIOZ (Drug) $369.86
- JARDIANCE (Drug) $363.70
- ZENPEP (Drug) $361.43
- UBRELVY (Drug) $330.96
- Rybelsus (Drug) $289.71
- TRELEGY ELLIPTA (Drug) $289.43
- ELIQUIS (Drug) $247.03
- XARELTO (Drug) $201.19
- MOUNJARO (Drug) $194.14
- ENTRESTO (Drug) $175.72
- Cologuard Collection Kit (Device) $164.39
- NUZYRA (Drug) $164.10
- LEQVIO (Drug) $148.37
- NURTEC ODT (Drug) $142.69
- PREVNAR 20 (Biological) $140.00
- INSPIRE (Device) $139.79
- Talicia (Drug) $136.45
- FANAPT (Drug) $111.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Cumberland
Mr. Eric Williams, Pa-C, PA-C
Physician Assistant — Payments: $4,162
Amy Biancone, Pac, PAC
Physician Assistant — Payments: $2,747
Stephanie Sydney, Pa-C, PA-C
Physician Assistant — Payments: $2,107
Rachel Lambright
Physician Assistant — Payments: $1,343
Ms. Natashia Vanslyke, Pa-C, PA-C
Physician Assistant — Payments: $1,163
Keeley Cook, Pa-C, PA-C
Physician Assistant — Payments: $1,110